AXNX News | Roxom Stocks

1 BTC

=

- USD

Loading market data...

AX

Mkt Cap

$7.6M

Volume

66.23K

Next Earnings

N/A

Chart Financials Earnings News About Insider Filings

Axonics Shares Fall Despite Australia's Approval for R20 SNM DeviceAxonics received regulatory approval from the Therapeutic Goods Administration in Australia to market its R20 rechargeable sacral neuromodulation (SNM) system, which features a 20-year functional life and reduced recharge frequency. However, Axonics' shares fell despite this positive development.Benzinga · Sep 27, 2024

All You Need to Know About Axonics (AXNX) Rating Upgrade to BuyAxonics (AXNX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).Zacks Investment Research · Mar 29, 2024

Axonics (AXNX) Gets CE Mark for Sacral Neuromodulation SystemAxonics' (AXNX) fourth-generation rechargeable Sacral Neuromodulation system will reduce the frequency of patient recharges significantly. The new form factor ensures ease of use.Zacks Investment Research · Mar 15, 2024

Beyond The Numbers: 7 Analysts Discuss Axonics StockAnalysts' ratings for Axonics (NASDAQ:AXNX) over the last quarter vary from bullish to bearish, as provided by 7 analysts. The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 0 6 0 0 Last 30D 0 0 1 0 0 1M Ago 0 0 0 0 0 2M Ago 0 0 5 0 0 3M Ago 1 0 0 0 0 The 12-month price targets, analyzed by analysts, offer insights with an average target of $71.29, a high estimate of $73.00, and a low estimate of $71.00. Witnessing a positive shift, the current average has risen by 0.69% from the previous average price target of $70.80. Analyzing Analyst Ratings: A Detailed Breakdown The perception of Axonics by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target Shagun Singh RBC Capital Maintains Sector Perform $71.00 - David Rescott Truist Securities Lowers Hold $71.00 $73.00 David Rescott Truist Securities Lowers Hold $71.00 $73.00 Adam Maeder Piper Sandler Lowers Neutral $71.00 $75.00 Mike Kratky Leerink Partners Announces Market Perform $71.00 - Larry Biegelsen Wells Fargo Raises Equal-Weight $71.00 $68.00 David Rescott Truist Securities Raises Buy $73.00 $65.00 Key Insights: Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or ...Full story available on Benzinga.comBenzinga · Feb 29, 2024

Axonics Modulation Technologies (AXNX) Q4 Earnings and Revenues Surpass EstimatesAxonics (AXNX) delivered earnings and revenue surprises of 116.67% and 0.37%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?Zacks Investment Research · Feb 28, 2024

American Well Corporation (AMWL) Reports Q4 Loss, Tops Revenue EstimatesAmerican Well Corporation (AMWL) delivered earnings and revenue surprises of 10.53% and 1%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?Zacks Investment Research · Feb 14, 2024

Zacks.com featured highlights include Axonics, Enerpac Tool Group, Cardinal Health and Acuity BrandsAxonics, Enerpac Tool Group, Cardinal Health and Acuity Brands are part of the Zacks Screen of the Week article.Zacks Investment Research · Feb 1, 2024

4 Stocks Backed by High Efficiency to Enrich Your PortfolioInvest in companies like Axonics (AXNX), Enerpac Tool Group (EPAC), Cardinal Health (CAH) and Acuity Brands (AYI) due to higher efficiency levels.Zacks Investment Research · Jan 31, 2024

Robinhood, Palo Alto Networks And 2 Other Stocks Insiders Are SellingThe Nasdaq 100 closed higher by more than 100 points on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders sell shares, it could be a preplanned sale, or could indicate their concern in the company’s prospects or that they view the stock as being overpriced. Insider sales should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a selling decision. Below is a look at a few recent notable insider sales. For more, check out Benzinga's insider transactions platform. Axonics The Trade: Axonics, Inc. (NASDAQ: AXNX) Chief Medical Officer Karen Noblett sold a total of 15,999 shares at an average price of $69.00. The insider received around $1.1 million from selling those shares. What’s Happening: Axonics announced a deal to be acquired by Boston Scientific. What Axonics Does: ...Benzinga · Jan 11, 2024

Analyst Scoreboard: 5 Ratings For AxonicsProviding a diverse range of perspectives from bullish to bearish, 5 analysts have published ratings on Axonics (NASDAQ:AXNX) in the last three months. Summarizing their recent assessments, the table below illustrates the evolving sentiments in the past 30 days and compares them to the preceding months. Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 2 3 0 0 0 Last 30D 0 0 0 0 0 1M Ago 1 0 0 0 0 2M Ago 0 0 0 0 0 3M Ago 1 3 0 0 0 In the assessment of 12-month price targets, analysts unveil insights for Axonics, presenting an average target of $70.0, a high estimate of $75.00, and a low estimate of $63.00. Experiencing a 6.98% decline, the current average is now lower than the previous average price target of $75.25. Deciphering Analyst Ratings: An In-Depth Analysis A clear picture of Axonics's perception among financial experts is painted with a thorough analysis of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets. Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target David Rescott Truist Securities Raises Buy $73.00 $65.00 Adam Maeder Piper Sandler Lowers Overweight $75.00 $84.00 Cecilia Furlong Morgan Stanley Lowers Overweight $69.00 $76.00 Mike Matson Needham Lowers Buy $63.00 $76.00 Mike Kratky Leerink Partners Announces Outperform $70.00 - Key Insights: Action Taken: In response to dynamic market conditions and company performance, analysts update their ...Full story available on Benzinga.comBenzinga · Jan 9, 2024

AX

AXNXAxonex AI Group Limited Class A Ordinary Shares

AXNX

Pay with—

Available Balance0.00

Your PositionYou don't own any AXNX yet.

Related Tickers

Earnings